The Future Is Set for Tourism’s Next Era as the Inaugural TOURISE Summit Opens
11.11.2025 13:51:00 CET | Business Wire | Press Release
With the bold ambition to rewrite the rules of travel, the inaugural TOURISE Summit under the patronage of His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister was officially opened today by H.E. Ahmed Al Khateeb, Minister of Tourism of Saudi Arabia and Chairman of TOURISE.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251111716065/en/
His Excellency Ahmed Al Khateeb, Saudi Arabia's Minister of Tourism and Chairman of TOURISE, opens the inaugural TOURISE Summit in Riyadh.
TOURISE ushers in a new era for global tourism, uniting ministers, delegates, and visionaries from around the world as the premier platform dedicated to shaping the future of global tourism.
Taking place from November 11-13, 2025, immediately following the 50th United Nations Tourism General Assembly, TOURISE is reimagining the way that sectors interact to find opportunities where competitors become partners where investments are optimized and where fragmented silos converge. The event aims to turn bold ideas into real-world solutions and catalyze transformative initiatives that will shape the next 50 years of the global tourism sector.
During his opening speech today, H.E. Ahmed Al Khateeb noted that there has never been a more urgent or opportune moment for convergence of sectors to shape global tourism, with the tourism sector having rebounded to historic highs, with international arrivals and investment surpassing pre-pandemic levels. However, he cautioned that at the same time, the sector faces unprecedented challenges and opportunities: rapid technological disruption, a generational shift toward sustainable and experience-driven travel, and an imperative to build resilience in the face of economic and environmental uncertainty and growing fragmentation around the globe.
His Excellency recognised that TOURISE has arrived at this inflection point, when the world is hungry for new models, new partnerships, and new solutions.
“TOURISE is more than an event, it is a platform for action where we will solve for the challenges all together that have long limited tourism’s full potential among them are challenges in skills, investment, infrastructure, sustainability, and digital transformation. It’s a space where we will work hand in hand to deliver the best outcomes for everyone: returns for investors; more accessible destinations and affordable experiences for travelers; jobs and prosperity for communities as the demand for travel increases. We are not here just to discuss ideas. We are here to act. That is why TOURISE exists.”
Over the course of its three days, TOURISE is set to host a number of key panels and talks featuring global leaders from across sectors. Notable global speakers include:
- Ariane Gorin, CEO, Expedia
- Ambassador Patricia Espinosa, Founder, onepoint5
- Gloria Guevara, Interim CEO, World Travel & Tourism Council
- Shaikha Nasser Al Nowais, Incoming Secretary General of UN Tourism
- Luis Maroto, CEO, Amadeus
- Francis Suarez, Mayor, Miami
- Paul Griffiths, CEO, Dubai Airports
- Lucia Penrod, Co-Founder & Owner, Nikki Beach
- Sébastien Bazin, CEO, Accor
- Eduardo Santander, CEO, European Travel Commission (ETC)
- Harvey Goldsmith CBE, Founder, Nvisible Productions
- Thomas Woldbye, CEO, Heathrow Airport
- Steve Hafner, Co-Founder & CEO, Kayak.com
The speaker line up showcases how TOURISE unites leaders from sectors rarely seen together, creating counterintuitive, boundary-breaking collaborations. These convergences are not just novel; they are the engine for new business models, improved traveler experiences, sustainable destination development and investment strategies that could only emerge from such a unique, multi-sector platform.
The Summit will cover the big questions redefining travel’s future from AI-powered experiences and frictionless borders to destination design, investment, and the race for tomorrow’s travelers, and transform them into action through high-powered ministerial dialogues, boardroom dialogues, main-stage keynotes and innovation showcases.
The winners of the very first TOURISE Awards will also be announced this evening, recognizing those places that exemplify destination excellence and cater to the evolving expectations of the modern traveler.
Powered by the Saudi Ministry of Tourism, TOURISE is more than a three-day summit, it is an always-on, global platform. Crucially, the conversations sparked in Riyadh will continue year-round platform through collaboration and cross-sector partnerships, turning bold ideas into real-world solutions.
About TOURISE
TOURISE is the world’s premier platform shaping a new horizon for global tourism.
Powered by the Saudi Ministry of Tourism, the inaugural TOURISE Summit will take place 11-13, November 2025 in Riyadh. TOURISE will convene visionaries from government, business, investment, tourism and technology communities to deliver high impact initiatives and transformative deals that will reset the industry and build a tourism sector that is sustainable, equitable, and future-focused.
Physically exclusive and digitally inclusive, TOURISE will ensure broad global participation while providing targeted access to visionaries shaping the future of global tourism. Following the Summit, TOURISE will extend as a year-round platform where bold ideas become real-world solutions.
This is where the next 50 years of tourism are shaped. Together, we are unstoppable.
For more information about TOURISE, visit www.TOURISE.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20251111716065/en/
Contacts
For further details contact: media@TOURISE.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom